Managers

Venture sinks its teeth into oral-care innovation

Redpoint eventures to raise $130 mln venture-capital fund

Redpoint eventures has set out to raise a $130 million venture-capital fund, according to a filing with the SEC.

OncoSynergy scores Series A funding

OncoSynergy, an oncology therapeutics spin-out from UCSF, has raised an undisclosed amount of Series A funding. Connecticut Innovations led the round with participation from other investors that included NLabs Inc and Korea Information & Communication Co. Ltd.

Yes VC targets $50 mln for maiden fund

San Francisco-based early-stage venture firm Yes VC is seeking to raise $50 million for its debut fund, according to an SEC filing. Yes VC was formed by Jyri Engeström, a former entrepreneur in residence at True Ventures and Caterina Fake, a founding partner at Founder Collective.

Summit, Battery, Canaan lead maturing portfolio at Nevada pension

Golden Ventures raises $72 mln for third seed fund

Canadian venture capital firm Golden Ventures has raised $72 million in committed capital for its third seed-stage fund. Golden Ventures III, the firm's largest fund to date, was backed by a range of new and returning limited partners. They include: Cendana Capital, Foundry Group Next, HarbourVest Partners, Kensington Capital Partners, Northleaf Capital Partners, Teralys Capital and Venture Investment Associates. It will invest in 20 to 25 early-stage technology companies in Canada and the United States. With Fund III's close, Golden said it promoted Jamie Rosenblatt to principal and hired Marianne Bulger to head the firm's people and platform team.

The new iNovia Capital and Canada’s scaling VC industry

The new iNovia Capital and Canada’s scaling VC industry

Canada’s venture industry is entering a new evolutionary phase as leading firms unveil big, bold plans for scaling brands, taking on new challenges, and filling market gaps. INovia Capital, a 10-year investor in North American tech companies, provides the latest and perhaps most ambitious example of the trend. Last month iNovia said it would blend its longstanding early-stage focus with an ability to do growth-equity deals, an initiative reportedly allied with a major US$500 million ($640 million) fund launch.

Foresite Capital raises $668 mln for fourth fund

San Francisco-based Foresite Capital, a healthcare and life sciences investment firm, has closed its fourth fund at $668 million. The fund's limited partners include university endowments, pension funds, insurance companies and foundations.

Third Rock’s Alexis Borisy on bringing the perspective of a healthcare investor to the NVCA chair